LGND
Ligand Pharmaceuticals Incorporated
$191.31
+$4.25(+2.27%)
66
Overall
40
Value
90
Tech
68
Quality
Market Cap
$3.56B
Volume
383.18K
52W Range
$93.58 - $194.44
Target Price
$184.29
Key Metrics Overview
| Market Cap | $3.56B | P/E Ratio | 617.13 |
| 52W High | $194.44 | 52W Low | $93.58 |
| Div Yield | N/A | Payout Ratio | 0.0% |
| EPS Growth 3Y | -28.1% | 52W Position | 96.9% |
| Overall Score | 66 | Value Score | 40 |
| Quality Score | 68 | Technical Score | 90 |
Growth Analysis
| EPS Current Est | $0.31 | EPS Next Est | $4.66 |
| EPS Growth Est | +1403.2% | DPS Growth 3Y | N/A |
Revenue (5Y)
EBITDA (5Y)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | LGND | $191.31 | +2.3% | 383.18K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Ligand Pharmaceuticals Incorporated Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW